Search Results
Keywords: "United Kingdom"United Nations approves WHO recommendation to reschedule cannabis in historic vote
The United Nations Commission on Narcotic Drugs (CND) on Wednesday accepted a World Health Organization (WHO) recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs.
Latin American cannabis exports continue to fall short of lofty expectations
Expectations that Latin America would become a significant exporter of cannabis for medical and scientific use have not yet materialized, with total export revenue from the continent estimated to be less than $15 million.
Another cannabis flower recall in Germany stemming from contamination
Gröbenzell, Germany-based Ever Pharma is recalling all batches of its cannabis flower product CanPharma 20/1 after detecting contamination above acceptable levels, Marijuana Business Daily has learned.
As competition grows in German medical cannabis flower market, sales strategy becomes key
The growing number of medical cannabis brands and products available to patients in Germany indicates that companies wanting to enter and succeed in that market need to think beyond simply offering a consistent supply of products.
Epidiolex maker GW Pharma reports record quarterly revenue of $137 million
United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex.